189 results on '"Lu, Zhong X."'
Search Results
2. Hypophosphatasia
3. Corrigendum to “Type 2 diabetes after a pregnancy with gestational diabetes among first nations women in Australia: The PANDORA study” [Diabetes Res. Clin. Pract. 181 (2021) 109092]
4. Relationship Between Urinary Phosphate and All-Cause and Cardiovascular Mortality in a National Population-Based Longitudinal Cohort Study
5. Type 2 diabetes after a pregnancy with gestational diabetes among first nations women in Australia: The PANDORA study
6. Is point of care renal function testing reliable screening pre-IV contrast administration?
7. Carnosine Did Not Affect Vascular and Metabolic Outcomes in Patients with Prediabetes and Type 2 Diabetes: A 14-Week Randomized Controlled Trial
8. Carnosine supplementation improves glucose control in adults with pre-diabetes and type 2 diabetes: a randomised controlled trial
9. Genetic testing in alpha-1 antitrypsin deficiency – to sequence or not
10. Aldosterone, Renin, and Aldosterone-to-Renin Ratio Variability in Screening for Primary Aldosteronism
11. Serum 25-Hydroxyvitamin D Deficiency and the 5-Year Incidence of CKD
12. Cystatin C estimated glomerular filtration rate and all‐cause and cardiovascular disease mortality risk in the general population: AusDiab study
13. Aldosterone, Renin, and Aldosterone-to-Renin Ratio Variability in Screening for Primary Aldosteronism.
14. 022 Nitrous oxide induced myelo-neuropathy
15. The new Roche Elecsys TSH assay conforms with current IFCC C-STFT standards
16. VITAMIN B12 – TIME TO GET ACTIVE
17. Inter-laboratory discordance of beta-2 microglobulin results: impact on the validity of the international staging system for multiple myeloma
18. Phagocyte extracellular traps in children with neutrophilic airway inflammation
19. INTER-LABORATORY COMPARISON OF BETA-2 MICROGLOBULIN AND ALBUMIN METHODS: IMPACT OF ASSAY VARIATION ON MULTIPLE MYELOMA STAGING
20. Global FT4 immunoassay standardization: an expert opinion review
21. Close monitoring is required in the neonate affected by maternal Graves disease due to the potential for both central hypothyroidism and primary hyperthyroidism
22. Serum 25-Hydroxyvitamin D Is Associated with Reduced Risk of Metabolic Syndrome at 5 Years: Results from a National, Population-Based Prospective Study (The Australian Diabetes, Obesity and Lifestyle Study — AusDiab)
23. Positive and negative interference in immunoassays following biotin ingestion: a pharmacokinetic study
24. Prevalence of vitamin D deficiency and its determinants in Australian adults aged 25 years and older: a national, population-based study
25. Low Serum 25-Hydroxyvitamin D Is Associated with Increased Risk of the Development of the Metabolic Syndrome at Five Years: Results from a National, Population-Based Prospective Study (The Australian Diabetes, Obesity and Lifestyle Study: AusDiab)
26. Serum 25-Hydroxyvitamin D, Calcium Intake, and Risk of Type 2 Diabetes After 5 Years: Results from a national, population-based prospective study (the Australian Diabetes, Obesity and Lifestyle study)
27. Is point of care renal function testing reliable screening pre-IV contrast administration?
28. Should rcpaqap blood gas program include instrument calculated parameters?
29. A curious family of stunted growth
30. Baseline parameters and response to gnrh: conclusions from an audit of 136 serial tests
31. New causes of old diseases. are we ready?
32. A1C for Screening and Diagnosis of Type 2 Diabetes in Routine Clinical Practice
33. Global FT4 immunoassay standardization: an expert opinion review.
34. 25-hydroxyvitamin D Levels and chronic kidney disease in the AusDiab (Australian Diabetes, Obesity and Lifestyle) study
35. Subclinical hypothyroidism during pregnancy: the Melbourne public hospitals consensus
36. The stability and variability of serum and plasma fibroblast growth factor-23 levels in a haemodialysis cohort
37. Reference intervals for neonatal thyroid function tests in the first 7 days of life
38. Effect of resistant starch on fecal bulk and fermentation-dependent events in humans
39. Arabinoxylan Fiber from a By-Product of Wheat Flour Processing Behaves Physiologically like a Soluble, Fermentable Fiber in the Large Bowel of Rats
40. Arabinoxylan fiber, a byproduct of wheat flour processing, reduces the postprandial glucose response in normoglycemic subjects
41. Close monitoring is required in the neonate affected by maternal Graves disease due to the potential for both central hypothyroidism and primary hyperthyroidism.
42. Cord blood metabolic markers are strong mediators of the effect of maternal adiposity on fetal growth in pregnancies across the glucose tolerance spectrum: the PANDORA study.
43. Establishing population and gestational age specific TSH reference intervals for common methods in Australia using the transference technique
44. Concentrating urine before electrophoresis for the detection of monoclonal free light chains is unnecessary and wasteful
45. Proton pump inhibitors are the most common cause of severe hypomagnesemia in a tertiary hospital
46. Establishing population and gestational age specific TFT reference intervals for the Abbott method using local data mining
47. Establishing population and gestational age specific tft reference intervals for the roche method using local data by data mining
48. Higher maternal serum prolactin levels are associated with reduced glucose tolerance during pregnancy
49. Pregnancy And Neonatal Diabetes Outcomes in Remote Australia: the PANDORA study-an observational birth cohort.
50. Arabinoxylan Fiber from a By-Product of Wheat Flour Processing Behaves Physiologically,like a Soluble, Fermentable Fiber in the Large Bowel of Rats
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.